Role of plasminogen activator inhibitor-1 in coronary pathophysiology

Area of Science:

• Cardiovascular Medicine
• Biochemistry
• Vascular Biology

Background:

• Percutaneous coronary intervention (PCI) is standard for obstructive coronary artery disease but has limitations.
• Target lesion failure and complications like in-stent restenosis and stent thrombosis remain significant challenges.
• Plasminogen activator inhibitor-1 (PAI-1) is implicated in arterial remodeling and thrombosis, with elevated levels linked to coronary artery disease.

Purpose of the Study:

• To review the current understanding of PAI-1 in vascular disease.
• To explore the potential role of PAI-1 in in-stent restenosis and stent thrombosis.
• To discuss PAI-1 as a potential mediator and therapeutic target in vascular disease.

Main Methods:

• Literature review of studies on PAI-1 and vascular disease.
• Analysis of PAI-1's function in cell migration and vascular thrombosis.
• Examination of PAI-1's association with coronary artery disease severity and prognosis.

Main Results:

• Elevated PAI-1 antigen levels are associated with coronary artery disease and metabolic syndrome.
• PAI-1 regulates cell migration and vascular thrombosis, suggesting a role in arterial remodeling.
• The precise role of PAI-1 as a mediator or therapeutic target in vascular disease requires further investigation.

Conclusions:

• PAI-1 is a protein of interest in vascular disease due to its role in thrombosis and arterial remodeling.
• Understanding PAI-1's involvement in in-stent restenosis and stent thrombosis is crucial for improving PCI outcomes.
• PAI-1 warrants further investigation as a potential biomarker, mediator, and therapeutic target for atherosclerotic coronary disease.